Back to Home
Product Approval 🌍 AU/AMA Level

Continental Listing: Gardasil 9 (Prefilled Syringe)

A
AMRH Secretariat
African Medicines Regulatory Harmonization (AMRH)
AMRH has granted a Positive Opinion for Gardasil 9 (Prefilled Syringe) (AMA0044).

Applicant: MSD (Pty) Ltd

Active Substance: Human Papillomavirus (HPV) Types 6, 11, 16, 18, 31, 33, 45, 52, 58

Indication: Active immunisation from age 9 years against HPV diseases: premalignant lesions and cancers of cervix, vulva, vagina, anus; genital warts

This product was listed in the 1st Edition - March 2025 and is now available for country-level submissions.

Manufacturing Sites: Merck Sharp & Dohme LLC, West Point, Pennsylvania, USA; MSD Ireland, Carlow, Ireland; Release: Merck Sharp & Dohme B.V., Haarlem, Netherlands

GMP Status: Compliant

Therapeutic Category: EMP-TC Category 1: Vaccine
Tags: continental listing emp-tc category 1: vaccine J07BM03
Published: March 25, 2025 Views: 8

Related Updates

Want to Share Your Updates?

Join RISP to share news, updates, and announcements with the regulatory community across Africa.